Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Eptifibatide Injection

Approval Number

国药准字H20213587

Company海南普利制药股份有限公司

Registration Date

July 20, 2021

Drug Information

Generic Name

依替巴肽注射液

Dosage Form

注射剂

Strength

10ml:20mg

Drug Type

化学药品

Registration Date

July 20, 2021

Company Information

Applicant Company

Company Name海南普利制药股份有限公司

Company Address

海口市美兰区桂林洋经济开发区

Manufacturing Company

Company Name海南普利制药股份有限公司

Company Address

海口市美兰区桂林洋经济开发区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy